http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-205698633-U
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ba3da9a6f1ec9b657d2cbee8d45a026d |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L33-04 |
| filingDate | 2016-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46fe1fcc9ad7ac1f20799d18d735e9a1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ea34f78f865e140c60f16a1c1c84d93 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b5dadeeebd36cdc62d04872c2263c56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dfc8951ea0e6867039cb98b204499c9a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11fabdbd2ac89558bd3241d234645f4b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0fee369acb5e2d8d24b2b19109557e6 |
| publicationDate | 2016-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-205698633-U |
| titleOfInvention | A kind of bracket for eluting medicament |
| abstract | This utility model provides a kind of bracket for eluting medicament, described bracket for eluting medicament is by rest body (1) and is coated in the medication coat of rest body inner surface and forms, described medication coat has three-decker, is followed successively by degradability polymeric layer (2), medicine layer (3) and degradability polymeric layer (4) from one layer of contact rest body.Bracket for eluting medicament of the present utility model can make the medicine of carrying have slow releasing function, antiinflammatory, the suppression effect such as vascular smooth muscle cell curing, antiplatelet adhesion is effectively played during slowly release, smooth muscle cell proliferation and platelet aggregation can be suppressed targetedly, promote blood vessel endothelialization again, the medicament elution phase can be controlled in 2 thoughtful 6 weeks, the time occurred with restenosis coincide, and effectively reduces the generation of restenosis. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112618119-A |
| priorityDate | 2016-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 41.